Dittus C, Streiff M, Ansell J: Bleeding and clotting in hereditary hemorrhagic telangiectasia. World J Clin Cases 3: 330, 2015.
Garg N, Khunger M, Gupta A, et al: Optimal management of hereditary hemorrhagic telangiectasia. J Blood Med 5: 206, 2014.
Govani F, Shovlin C: Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet 17: 860, 2009.
Shovlin CL, Guttmacher AE, Buscarini E, et al: Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91: 66, 2000.
Botella L, Albinana V, Ojeda-Fernandez L, et al: Research on potential biomarkers in hereditary hemorrhagic telangiectasia. Front Genet 6: 115, 2015.
Hunt K, Kissel R, Vidal L: Progressive widespread cutaneous telangiectasias. AMA Dermatol 150: 1103, 2014.
McDonald J, Wooderchak W, Whitehead K, et al: Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era. Front Genet 6: 8, 2015.
Boza JC, Dorn T, Oliveira FB, et al: Case for diagnosis: hereditary hemorrhagic telangiectasia. An Bras Dermatol 89: 999, 2014.
Hereditary hemorrhagic telangiectasia (HHT), which is also known as Osler-Weber-Rendu syndrome, is a group of related disorders characterized by the development of arteriovenous malformations. These malformations occur in almost all organs but predominantly in the skin, intestines, liver, lungs, and brain. This is a case report of a patient with cutaneous manifestations of HHT in the lower extremities as diagnosed by his podiatric physician. To our knowledge, the literature does not present any case reports in which cutaneous manifestations of the lower extremities followed by a further work-up allowed a diagnosis of HHT.